| Particulars |
|
|
|
| Company Name
| Piramal Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
1,331.35 |
B.V. (₹) |
61.20 |
| Sales(₹ Cr.) |
4,782.01 |
NP (₹ Cr.) |
767.53 |
| NP Var% |
11.00 |
Div% |
0.00 |
| CPS(₹) |
7.70 |
EPS (₹) |
5.80 |
| Traded Value(₹ Lakhs) |
482.35 |
52 Week High |
221.00 |
| 52 Week Low |
133.00 |
Price BSE |
177.00 |
| Price NSE |
177.00 |
Market Capital (₹ Cr.) |
23,578.18 |
| P/C Ratio |
23.00 |
P/E Ratio |
30.70 |
| Price Vs.BV |
2.89 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,489.06 |
| NP(₹ Cr.) |
313.33 |
NP Var % |
13.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
4,897.03 |
| OPM |
-2.96 |
NP |
642.75 |
| NP Var% |
11.40 |
EPS |
5.77 |
| PE |
30.69 |
|
|